Interested in innovation, entrepreneurship, design and 3D printing? Join us for the new BioVenture eLab SolidWorks (3D-printing design software) course! This course will take place every Monday from 5:00-7:00pm for 5-weeks.

Turning an idea into a company is no easy task... By exploring case studies from the activities of MEDX Xelerator (an incubator for medical device companies), we will discuss how to turn the impossible to possible, the main ingredients that create great medical device companies, and how to raise seed funding to...

Weill Cornell Medicine BioVenture eLab and Entrepreneurship at Cornell will join forces at this exciting event celebrating entrepreneurship and innovation in the bioscience space. This event will feature discussions from an exciting array of leaders from the biopharma, investment, and entrepreneurial...

Venk Varadan, Cofounder and CEO, Nanowear Inc. Nanowear is the leading developer of patented, textile-based nanosensor technology with applications across a broad array of medical conditions and chronic disease states. The company’s proprietary technology provides medical professionals with accurate and continuous diagnostic data...

Join us for an evening to discuss electronics, Arduinos, and innovative medical ideas. We will meet in the new MakerSpace for this is a hands-on workshop for those interested in the field.

You're invited to take part in the Health Hackathon, an inter-disciplinary weekend event in collaboration with Cornell University, Ithaca! All backgrounds are encouraged to participate in this competition, which is also a 'coopetition' to see far we can stretch the applications of technology to health care,...

Are you a scientist or clinician with an invention or business idea you would like to commercialize? Weill Cornell Medicine offers a unique program focused on helping to launch biomedical business ideas! Selected teams will go through an intensive 10-week mentoring program to develop and strengthen business...

Adaptive Biotechnologies is an early stage company that is viewing the immune system using a combination of DNA sequencing and high-powered computation. They have raised $195 million from investors, and recently concluded a deal with Genentech with a massive $300 million upfront. Come and hear Dr. Sharon Benzeno, PhD, MBA, Senior Vice...

The Weill Cornell Medicine BioVenture eLab hosted an expert on immigration law to discuss the in's and out's of issues to consider while launching or joining an early stage startup. With: Alexander G. Rojas, Partner, Barst Mukamal & Kleiner LLP